1
|
Llauradó A, Gratacòs-Viñola M, Vidal-Taboada JM, Sanchez-Tejerina D, Salvadó M, Sotoca J, López-Diego V, Alemañ J, Restrepo-Vera JL, Lainez E, Seoane JL, Raguer N, Juntas-Morales R. Usefulness of somatosensory evoked potentials for monitoring the clinical course of patients with chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2024. [PMID: 39132869 DOI: 10.1002/mus.28234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 07/30/2024] [Accepted: 07/31/2024] [Indexed: 08/13/2024]
Abstract
INTRODUCTION/AIMS Somatosensory evoked potentials (SSEPs) are described as a supportive tool to diagnose chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); however, there is a lack of studies determining the effectiveness of SSEPs in monitoring the clinical course of individuals with this condition. The aims of this study are to evaluate the utility of SSEPs in monitoring patients with CIDP and to assess their association with clinical outcomes following immunomodulatory therapy. METHODS This was a single-center retrospective observational study that included patients who met European Federation of Neurological Societies and Peripheral Nerve Society criteria for CIDP between 2018 and 2023. SSEPs were performed at diagnosis and during follow-up after the start of immunomodulatory treatment. Fisher's exact test was employed to assess the association between clinical improvement and SSEP improvement. RESULTS Eighteen patients were included in the study. Ten patients had a typical CIDP pattern and 11 were male. In 17, SSEPs were abnormal prior to the start of immunomodulatory treatment. In patients who showed clinical improvement with immunomodulatory therapy, we observed that 15/17 had partial or complete improvement in SSEPs. Patients who showed no clinical improvement with first-line treatment exhibited worsening SSEPs. There was a significant association between clinical and SSEPs improvement (p = 0.009). DISCUSSION We observed a positive association between improvement in SSEPs and clinical improvement in patients with CIDP. Our data suggest that SSEPs may be useful for monitoring the clinical course of patients with CIDP, but additional, larger studies are needed.
Collapse
Affiliation(s)
- A Llauradó
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - M Gratacòs-Viñola
- Department of Clinical Neurophysiology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - J M Vidal-Taboada
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - D Sanchez-Tejerina
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - M Salvadó
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - J Sotoca
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - V López-Diego
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - J Alemañ
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - J L Restrepo-Vera
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - E Lainez
- Department of Clinical Neurophysiology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - J L Seoane
- Department of Clinical Neurophysiology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - N Raguer
- Department of Clinical Neurophysiology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - R Juntas-Morales
- Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain
| |
Collapse
|
2
|
Thirouin J, Petiot P, Antoine JC, André-Obadia N, Convers P, Gavoille A, Bouhour F, Rheims S, Camdessanché JP. Usefulness and prognostic value of diagnostic tests in patients with possible chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2022; 66:304-311. [PMID: 35661382 DOI: 10.1002/mus.27655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 05/23/2022] [Accepted: 05/28/2022] [Indexed: 11/09/2022]
Abstract
INTRODUCTION/AIMS Recent guidelines define chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and possible CIDP. The aims of our study were to evaluate the value of diagnostic tests to support the diagnosis of CIDP in patients with possible CIDP and to identify prognostic factors of therapeutic success. METHODS We conducted an observational retrospective two-center study between 2014 and 2019. We selected patients with a clinical presentation suggesting CIDP, but whose electrodiagnostic (EDX) test results did not meet the EFNS/PNS 2021 criteria. We analyzed epidemiologic and clinical features, axonal loss on EDX, cerebrospinal fluid (CSF), somatosensory evoked potentials (SSEPs), plexus magnetic resonance imaging (MRI), nerve biopsy, and therapeutic response. RESULTS We selected 75 patients, among whom 30 (40%) responded to treatment. The positivity rates of CSF analysis, MRI and SSEPs were not influenced by the clinical presentation or by the delay between symptom onset and medical assessment. A high protein level in CSF, female gender, and a relapsing-remitting course predicted the therapeutic response. DISCUSSION It is important to properly diagnose suspected CIDP not meeting EFNS/PNS 2021 EDX criteria by using supportive criteria. Specific epidemiological factors and a raised CSF protein level predict a response to treatment. Further prospective studies are needed to improve diagnosis and the prognostic value of diagnostic tests in CIDP.
Collapse
Affiliation(s)
- Jeanne Thirouin
- Department of Neurology, Centre Hospitalier de Valence, Valence, France
| | - Philippe Petiot
- Electroneuromyography and Neuromuscular Diseases Department, Centre Médicina, Lyon, France
| | | | - Nathalie André-Obadia
- Department of Functional Neurology and Epileptology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France
| | - Philippe Convers
- Department of Neurology, University Hospital, Saint-Etienne, France
| | - Antoine Gavoille
- Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France
| | - Françoise Bouhour
- Department of Neurology, Centre Hospitalier de Valence, Valence, France
| | - Sylvain Rheims
- Department of Functional Neurology and Epileptology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France
| | | |
Collapse
|
3
|
Fustes OJH, Kay CSK, Lorenzoni PJ, Ducci RDP, Werneck LC, Scola RH. Somatosensory evoked potentials in clinical practice: a review. ARQUIVOS DE NEURO-PSIQUIATRIA 2021; 79:824-831. [PMID: 34669817 DOI: 10.1590/0004-282x-anp-2020-0427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Accepted: 12/28/2020] [Indexed: 11/22/2022]
Abstract
The authors present a review of the current use of somatosensory evoked potentials (SSEPs) in neurological practice as a non-invasive neurophysiological technique. For this purpose we have reviewed articles published in English or Portuguese in the PubMed and LILACS databases. In this review, we address the role of SSEPs in neurological diseases that affect the central nervous system and the peripheral nervous system, especially in demyelinating diseases, for monitoring coma, trauma and the functioning of sensory pathways during surgical procedures. The latter, along with new areas of research, has become one of the most important applications of SSEPs.
Collapse
Affiliation(s)
- Otto Jesus Hernández Fustes
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| | - Cláudia Suemi Kamoi Kay
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| | - Paulo José Lorenzoni
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| | - Renata Dal-Prá Ducci
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| | - Lineu Cesar Werneck
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| | - Rosana Herminia Scola
- Universidade Federal do Paraná, Complexo Hospital de Clínicas, Departamento de Clínica Médica, Serviço de Neurologia, Serviço de Doenças Neuromusculares e Desmielinizantes, Curitiba PR, Brazil
| |
Collapse
|
4
|
Shelly S, Shouman K, Paul P, Engelstad J, Amrami KK, Spinner RJ, Dubey D, Vazquez Do Campo R, Dyck PJ, Klein CJ, Dyck PJB. Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus. Neurology 2021; 96:e2078-e2089. [PMID: 33653905 PMCID: PMC8166448 DOI: 10.1212/wnl.0000000000011792] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Accepted: 01/28/2021] [Indexed: 12/24/2022] Open
Abstract
Objective Sensory loss with normal nerve conduction studies (NCS) from focal sensory root inflammatory demyelination is characteristic of chronic immune sensory polyradiculopathy (CISP). However, nonpure cases involving motor and distal sensory nerves exist (CISP-plus). We hypothesize that CISP-plus and CISP are fundamentally part of the same syndrome through comparison of clinical, neurophysiologic, and pathologic features. Methods CISP-plus (primary dorsal root with lesser motor and sensory nerve involvement) and CISP cases were retrospectively analyzed (1986–2019). Results We identified 44 CISP-plus and 28 CISP cases (n = 72) with 86% (38/44) of patients with CISP-plus and 79% (22/28) of patients with CISP experiencing imbalance. On examination, large fiber sensory loss was present in 98% (43/44) of patients with CISP-plus and 96% (27/28) of patients with CISP. Gait ataxia was evident in 93% (41/44) of patients with CISP-plus and 79% (22/28) of patients with CISP. Mild distal weakness was common in CISP-plus (75%, 33/44). NCS showed mild abnormalities in all patients with CISP-plus and were normal (by definition) in all patients with CISP. Elevated CSF protein, slowing of somatosensory evoked potentials, and MRI root enhancement occurred in most CISP-plus and CISP cases. Eleven CISP-plus nerve biopsies showed loss of large myelinated fibers and onion-bulb formations, most prominent in rootlet biopsies. Immunotherapy resulted in marked improvement of gait ataxia in 84% (27/32) of patients with CISP-plus and 93% (13/14) of patients with CISP with return to normal neurologic examination in half (25/46). Conclusion The recognition of CISP-plus expands the spectrum of CIDP by combining CISP-plus (predominant sensory polyradiculopathy with mild motor and sensory nerve involvement) with pure CISP (focal sensory polyradiculopathy) together as proximal sensory CIDP.
Collapse
Affiliation(s)
- Shahar Shelly
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Kamal Shouman
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Pritikanta Paul
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - JaNean Engelstad
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Kimberly K Amrami
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Robert J Spinner
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Divyanshu Dubey
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Rocio Vazquez Do Campo
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - Peter J Dyck
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN.
| | - Christopher J Klein
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN
| | - P James B Dyck
- From the Departments of Neurology (S.S., K.S., P.P., D.D., R.V.D.C., P.J.D., C.J.K., P.J.B.D.), Laboratory Medicine and Pathology (J.E., D.D., C.J.K.), Radiology (K.K.A.), and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN.
| |
Collapse
|
5
|
Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain 2020; 143:3214-3224. [PMID: 33155018 PMCID: PMC7719025 DOI: 10.1093/brain/awaa265] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 06/07/2020] [Accepted: 06/17/2020] [Indexed: 12/11/2022] Open
Abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum of autoimmune diseases of the peripheral nerves, causing weakness and sensory symptoms. Diagnosis often is challenging, because of the heterogeneous presentation and both mis- and underdiagnosis are common. Nerve conduction study (NCS) abnormalities suggestive of demyelination are mandatory to fulfil the diagnostic criteria. On the one hand, performance and interpretation of NCS can be difficult and none of these demyelinating findings are specific for CIDP. On the other hand, not all patients will be detected despite the relatively high sensitivity of NCS abnormalities. The electrodiagnostic criteria can be supplemented with additional diagnostic tests such as CSF examination, MRI, nerve biopsy, and somatosensory evoked potentials. However, the evidence for each of these additional diagnostic tests is limited. Studies are often small without the use of a clinically relevant control group. None of the findings are specific for CIDP, meaning that the results of the diagnostic tests should be carefully interpreted. In this update we will discuss the pitfalls in diagnosing CIDP and the value of newly introduced diagnostic tests such as nerve ultrasound and testing for autoantibodies, which are not yet part of the guidelines.
Collapse
Affiliation(s)
- Filip Eftimov
- Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Ilse M Lucke
- Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Luis A Querol
- Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Centro para la Investigación en Red en Enfermedades Raras (CIBERER), Madrid, Spain
| | | | - Camiel Verhamme
- Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
6
|
Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurol Sci 2020; 41:2495-2501. [PMID: 32212008 PMCID: PMC7419376 DOI: 10.1007/s10072-020-04351-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 03/16/2020] [Indexed: 12/14/2022]
Abstract
Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nervous system, sometimes including the central nervous system. The aim of the study was the assessment of the prevalence of central sensory impairment and its reliance on peripheral nerve damage in patients with CIDP. Material and methods Multimodal (visual—VEP, brainstem auditory—BAEP, somatosensory—SEP) evoked potentials (EPs) were studied in 24 patients diagnosed with CIDP. The results were compared with neurographic parameters of sensory responses. The control group consisted of 35 healthy volunteers selected with respect to age and sex. Results Mean latency of most components of EP were considerably prolonged in patients compared with the control group. There were no correlations between the P100 VEP latency and the peripheral sensory parameters. Statistically significant negative correlations were obtained between BAEP and SEP responses and the amplitude and sensory conduction velocity of peripheral nerves. The inter-latencies were also longer. Conclusions The authors indicated to the possibility of central sensory involvement in patients with CIDP, especially based on the prolonged inter-latency of BAEPs with simultaneously confirmed root affection. The severity of central damage correlates with the degree of peripheral nerve impairment.
Collapse
|
7
|
Rodríguez Y, Vatti N, Ramírez-Santana C, Chang C, Mancera-Páez O, Gershwin ME, Anaya JM. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. J Autoimmun 2019; 102:8-37. [DOI: 10.1016/j.jaut.2019.04.021] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 04/13/2019] [Accepted: 04/23/2019] [Indexed: 12/12/2022]
|
8
|
Clerici AM, Nobile-Orazio E, Mauri M, Squellati FS, Bono GG. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy. BMC Neurol 2017; 17:127. [PMID: 28668085 PMCID: PMC5494125 DOI: 10.1186/s12883-017-0906-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Accepted: 06/22/2017] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Chronic immune sensory polyradiculopathy (CISP) identifies a progressive acquired peripheral dysimmune neuropathy recognized as a chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) variant. We describe a young woman with a thirteen-year history of CISP with a belated variable response to intravenous immunoglobulin (IVIG) and an almost erratic anticipation of symptoms between IVIG cycles. The association of IVIG and corticosteroids, immunosuppressants, plasmapheresis, did not lead to clinical improvement and was characterized by significant side effects. We evaluated a combined clinical and somatosensory evoked potentials (SSEPs) approach aimed to identify possible predictive parameters concerning the effect and duration of each IVIG administration. Neurologic disability was evaluated using INCAT - Overall Disability Sum Score (INCAT-ODSS). CASE PRESENTATION A 30-year-old woman presented on 2004 for the subacute onset of asymmetric paresthesias in the lower limbs over the previous six months. The symptoms had been relapsing-remitting during the first four months, followed by a slow progression, resulting in limbs ataxia and a progressive gait disturbance requiring Canadian crutches. Motor and sensory nerve conduction studies and electromyographic evaluation were into normal limits. Median SSEPs were normal, while tibial SSEPs were characterised by the bilateral absence of both lumbar and cortical responses. Cerebrospinal fluid detected an increased protein concentration, while spinal MRI showed a pronounced thickening of the sacral nerve roots, together with a tube-shaped enlargement. These findings led to the diagnosis of CISP and the patient was treated with IVIG reaching a stable remission over the following 9 years. In early 2014, the patient began to show a variable response to treatment with erratic anticipation of sensory disturbances, and a more pronounced walking disability: corticosteroids, plasmapheresis, mycophenolate mofetil and cyclophosphamide were uneffective and burdened by relevant side effects. To better assess the response to IVIG in terms of time-effect, consistency and duration, we have combined a scheduled clinical and SSEPs evaluation during and after each IVIG cycle. CONCLUSIONS The correlation between the neurophysiological data and the INCAT-ODSS scores has allowed the modulation of IVIG cycles with a significant reduction of the clinical fluctuations and disability. SSEPs may therefore represent an useful and recommended additional aid for the treatment schedule of this rare clinical form.
Collapse
Affiliation(s)
- Angelo Maurizio Clerici
- Neurology Unit, Circolo & Macchi Foundation Hospital - Insubria University - DBSV, Viale L. Borri 57, 21100, Varese, Italy.
| | - Eduardo Nobile-Orazio
- 2nd Neurology, Humanitas Clinical and Research Institute, Department of Medical Biotechnology and Translational Medicine (BIOMETRA), Milan University, Rozzano, Milan, Italy
| | - Marco Mauri
- Neurology Unit, Circolo & Macchi Foundation Hospital - Insubria University - DBSV, Viale L. Borri 57, 21100, Varese, Italy
| | - Federico Sergio Squellati
- Neurology Unit, Circolo & Macchi Foundation Hospital - Insubria University - DBSV, Viale L. Borri 57, 21100, Varese, Italy
| | - Giorgio Giovanni Bono
- Neurology Unit, Circolo & Macchi Foundation Hospital - Insubria University - DBSV, Viale L. Borri 57, 21100, Varese, Italy
| |
Collapse
|
9
|
Potentiels évoqués somesthésiques dans les polyradiculonévrites inflammatoires chroniques. Neurophysiol Clin 2016. [DOI: 10.1016/j.neucli.2016.05.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
10
|
Morizot-Koutlidis R, André-Obadia N, Antoine JC, Attarian S, Ayache S, Azabou E, Benaderette S, Camdessanché JP, Cassereau J, Convers P, d’Anglejean J, Delval A, Durand MC, Etard O, Fayet G, Fournier E, Franques J, Gavaret M, Guehl D, Guerit JM, Krim E, Kubis N, Lacour A, Lozeron P, Mauguière F, Merle PE, Mesrati F, Mutschler V, Nicolas G, Nordine T, Pautot V, Péréon Y, Petiot P, Pouget J, Praline J, Salhi H, Trébuchon A, Tyvaert L, Vial C, Zola JM, Zyss J, Lefaucheur JP. Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice. Neurophysiol Clin 2015; 45:131-42. [DOI: 10.1016/j.neucli.2015.04.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Revised: 03/31/2015] [Accepted: 04/02/2015] [Indexed: 12/14/2022] Open
|
11
|
Koutlidis R, Ayrignac X, Pradat PF, Le Forestier N, Léger JM, Salachas F, Maisonobe T, Fournier E, Viala K. Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies. Neurophysiol Clin 2014; 44:267-80. [DOI: 10.1016/j.neucli.2014.08.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2013] [Revised: 08/07/2014] [Accepted: 08/08/2014] [Indexed: 10/24/2022] Open
|